TrialPanorama/TrialPanorama-database huggingface dataset:
Study 1568426 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1568426 — Surrogate Endpoint (SUR): Blood pressure
Study 24212124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24212124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24212124 — Safety Biomarker (SAF): IL-6 and IL-10
Study 16832224 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29459120 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 16736131 — Surrogate Endpoint (SUR): Blood pressure
Study 10898316 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 3105568 — Surrogate Endpoint (SUR): Blood pressure
Study 27198484 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 12885487 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 12885487 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 8526698 — Surrogate Endpoint (SUR): Blood pressure
Study 26894591 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 26894591 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19101420 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 3780991 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 15562712 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 9506856 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24895144 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 24895144 — Surrogate Endpoint (SUR): Blood pressure
Study 20617176 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18479895 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 11788381 — Surrogate Endpoint (SUR): Serum uric acid
Study 10027480 — Surrogate Endpoint (SUR): Blood pressure
Study 27643343 — Surrogate Endpoint (SUR): Blood pressure
Study 18616675 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 14571615 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 10918719 — Surrogate Endpoint (SUR): Blood pressure
Study 3699692 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 3699692 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study 30832713 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 19747781 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 11889006 — Safety Biomarker (SAF): Reactive oxygen species
Study 15207885 — Surrogate Endpoint (SUR): Bone mineral density
Study 30987603 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30987603 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 30987603 — Surrogate Endpoint (SUR): Blood pressure
Study 25573527 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25573527 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 23564919 — Surrogate Endpoint (SUR): Blood pressure
Study 18841284 — Predictive Biomarker (PRD): RNH1 mRNA
Genes: RNH1; PRI; RNH
Study 31430297 — Safety Biomarker (SAF): miR-142
Genes: MIR142
Study 25300863 — Surrogate Endpoint (SUR): Serum creatinine
Study 23023308 — Surrogate Endpoint (SUR): Blood pressure
Study 17646693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 10071291 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 24144472 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24144472 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 20214338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20214338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9458489 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9458489 — Surrogate Endpoint (SUR): Blood pressure
Study 7948453 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 28459938 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28459938 — Surrogate Endpoint (SUR): Pathological complete response
Study 23602614 — Safety Biomarker (SAF): Reactive oxygen species
Study 24268704 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 20635179 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 20635179 — Predictive Biomarker (PRD): FMN1 mRNA
Genes: FMN1; FMN; LD
Study 23886139 — Predictive Biomarker (PRD): CD82 mRNA
Genes: CD82; KAI1; SAR2; ST6; TSPAN27
Study 23886139 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 23886139 — Predictive Biomarker (PRD): CD9 mRNA
Genes: CD9; MIC3; TSPAN29; GIG2
Study 8275620 — Surrogate Endpoint (SUR): Blood pressure
Study 24225816 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 17472478 — Surrogate Endpoint (SUR): Blood pressure
Study 17472478 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 802644 — Surrogate Endpoint (SUR): Blood pressure
Study 25679998 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23593253 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23731674 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 18258423 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 12925055 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7950612 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7950612 — Surrogate Endpoint (SUR): Serum creatinine
Study 7950612 — Surrogate Endpoint (SUR): Blood pressure
Study 2886560 — Surrogate Endpoint (SUR): Blood pressure
Study 23380881 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18097226 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 2859703 — Surrogate Endpoint (SUR): Blood pressure
Study 2859703 — Surrogate Endpoint (SUR): Serum potassium
Study 29552766 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19735259 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 7643540 — Surrogate Endpoint (SUR): Blood pressure
Study 2677610 — Surrogate Endpoint (SUR): Serum triglycerides
Study 2677610 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15692318 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 9819503 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 9819503 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25747273 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 18067986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10643405 — Predictive Biomarker (PRD): OTOR mRNA
Genes: OTOR; FDP; MIAL; UNQ3054/PRO9873
Study 10643405 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 7051741 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 19188808 — Surrogate Endpoint (SUR): Blood pressure
Study 11865834 — Predictive Biomarker (PRD): SFPQ mRNA
Genes: SFPQ; PSF
Study 10588294 — Surrogate Endpoint (SUR): Blood pressure
Study 17937690 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 30586727 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 27522513 — Surrogate Endpoint (SUR): Serum creatinine
Study 23271695 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23271695 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21733979 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 7117360 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 7117360 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 27090032 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 20015098 — Predictive Biomarker (PRD): DMRTA1 mRNA
Genes: DMRTA1; DMO
Study 17888700 — Surrogate Endpoint (SUR): Bone mineral density
Study 2911205 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 10792161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 29066464 — Surrogate Endpoint (SUR): Forced vital capacity
Study 1879271 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 26946343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26826629 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26826629 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 27569033 — Predictive Biomarker (PRD): RHOJ mRNA
Genes: RHOJ; ARHJ; RASL7B; RHOI; TCL
Study 20356687 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 17942524 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 17942524 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 17942524 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 12629094 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 29625440 — Surrogate Endpoint (SUR): Blood pressure
Study 22868212 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 31286921 — Surrogate Endpoint (SUR): Blood pressure
Study 31286921 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26752690 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26752690 — Surrogate Endpoint (SUR): Blood pressure
Study 24706091 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 19636555 — Predictive Biomarker (PRD): GGH mRNA
Genes: GGH
Study 19636555 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 1553933 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1553933 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22753219 — Surrogate Endpoint (SUR): Blood pressure
Study 2568765 — Surrogate Endpoint (SUR): Blood pressure
Study 26802011 — Surrogate Endpoint (SUR): Blood pressure
Study 31662165 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 28981592 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 18579227 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 26979583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26979583 — Surrogate Endpoint (SUR): Blood pressure
Study 16829344 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 16829344 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 10971543 — Surrogate Endpoint (SUR): Bone mineral density
Study 30368666 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 18753861 — Monitoring Biomarker (MOI): HBV DNA
Study 8510517 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 8510517 — Surrogate Endpoint (SUR): Blood pressure
Study 2881420 — Surrogate Endpoint (SUR): Blood pressure
Study 25862614 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25862614 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21788602 — Surrogate Endpoint (SUR): Blood pressure
Study 21788602 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2681858 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2681858 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25441094 — Surrogate Endpoint (SUR): Blood pressure
Study 25441094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18409002 — Monitoring Biomarker (MOI): HBV DNA
Study 13680248 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 10718508 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 29544449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29544449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19788461 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 19788461 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15617455 — Surrogate Endpoint (SUR): Blood pressure
Study 9561096 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 3583456 — Surrogate Endpoint (SUR): Blood pressure
Study 23002547 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23002547 — Monitoring Biomarker (MOI): HBV DNA
Study 9110278 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9110278 — Surrogate Endpoint (SUR): Blood pressure
Study 1765033 — Surrogate Endpoint (SUR): Blood pressure
Study 26796052 — Predictive Biomarker (PRD): CX3CL1 mRNA
Genes: CX3CL1; FKN; NTT; SCYD1; A-152E5.2
Study 26796052 — Predictive Biomarker (PRD): SGCA mRNA
Genes: SGCA; ADL; DAG2
Study 15835374 — Surrogate Endpoint (SUR): Blood pressure
Study 15835374 — Surrogate Endpoint (SUR): Serum creatinine
Study 27199859 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 18443566 — Surrogate Endpoint (SUR): Blood pressure
Study 9289706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 6228196 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6228196 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28480343 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 30741747 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 20634018 — Surrogate Endpoint (SUR): Blood pressure
Study 14715050 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 14715050 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 31665326 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 8382132 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 31384411 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31384411 — Surrogate Endpoint (SUR): Blood pressure
Study 31384411 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30258212 — Surrogate Endpoint (SUR): Bone mineral density
Study 22471362 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 22471362 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 20860913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20860913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19516153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19516153 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19516153 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 19516153 — Safety Biomarker (SAF): Cytochrome c
Study 16944396 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30904221 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 28413925 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 28413925 — Surrogate Endpoint (SUR): Blood pressure
Study 25136638 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25136638 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 15338687 — Surrogate Endpoint (SUR): Bone mineral density
Study 11229829 — Surrogate Endpoint (SUR): Blood pressure
Study 11229829 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26096765 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 18090169 — Surrogate Endpoint (SUR): Serum creatinine
Study 7993983 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9583551 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 8580227 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 27865117 — Safety Biomarker (SAF): Reactive oxygen species
Study 24383855 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29160731 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21182491 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 9050975 — Surrogate Endpoint (SUR): Blood pressure
Study 27315583 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27315583 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 27315583 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 27315583 — Predictive Biomarker (PRD): Hormone receptor
Study 9586668 — Surrogate Endpoint (SUR): Bone mineral density
Study 24163121 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 15083369 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Growth/differentiation factor 8
Genes: MSTN; GDF8
Study 15083369 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9579838 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8279942 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 3183852 — Surrogate Endpoint (SUR): Blood pressure
Study 29017282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29017282 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 16983600 — Surrogate Endpoint (SUR): Blood pressure
Study 8045656 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 3772096 — Surrogate Endpoint (SUR): Blood pressure
Study 12498545 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 1638252 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 14512671 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 14512671 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 1829030 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 27957678 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 27957678 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25194621 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24651278 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 15291377 — Surrogate Endpoint (SUR): Blood pressure
Study 31597484 — Surrogate Endpoint (SUR): Blood pressure
Study 22430972 — Monitoring Biomarker (MOI): HBV DNA
Study 17454965 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17454965 — Surrogate Endpoint (SUR): Blood pressure
Study 339865 — Surrogate Endpoint (SUR): Serum uric acid
Study 25826620 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23975232 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 21392622 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 21392622 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 7954556 — Surrogate Endpoint (SUR): Blood pressure
Study 29494398 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 31451342 — Safety Biomarker (SAF): Hyaluronic acid
Study 22814006 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 22814006 — Predictive Biomarker (PRD): ANKK1 mRNA
Genes: ANKK1; PKK2; SGK288
Study 22814006 — Predictive Biomarker (PRD): SLC6A3 mRNA
Genes: SLC6A3; DAT1
Study 22814006 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 22814006 — Predictive Biomarker (PRD): MAOA mRNA
Genes: MAOA
Study 19558471 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study 19558471 — Predictive Biomarker (PRD): CA2 mRNA
Genes: CA2
Study 3051990 — Surrogate Endpoint (SUR): Blood pressure
Study 31568130 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 31568130 — Predictive Biomarker (PRD): AMHR2 mRNA
Genes: AMHR2; AMHR; MISR2
Study 31568130 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 31568130 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 31568130 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study 31568130 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 27870712 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 27870712 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8750803 — Surrogate Endpoint (SUR): Serum calcium
Study 31152038 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HSPB8 mRNA
Genes: HSPB8; CRYAC; E2IG1; HSP22; PP1629
Study 26996228 — Surrogate Endpoint (SUR): Blood pressure
Study 26996228 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 20665492 — Surrogate Endpoint (SUR): Blood pressure
Study 11127861 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 24070115 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24070115 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 20447654 — Predictive Biomarker (PRD): TP53INP1 mRNA
Genes: TP53INP1; P53DINP1; SIP
Study 10655439 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 20299186 — Surrogate Endpoint (SUR): Bone mineral density
Study 16170293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 12826840 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 25149706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 25149706 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 25149706 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 25149706 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 25149706 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 25149706 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22829023 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12167276 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31831868 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 31831868 — Predictive Biomarker (PRD): TG mRNA
Genes: TG